Dawit A. Yohannes

Dawit A. Yohannes

Auto-generated profile, based on publicly available information

Dawit A. Yohannes

Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in Science Immunology
Verified
Journal Article
Closed access
JSJoona Sarkkinen
Joona Sarkkinen
DYDawit A. Yohannes
Dawit A. Yohannes
NKNea Kreivi
Nea Kreivi
PDPia Dürnsteiner
Pia Dürnsteiner
AEAlexandra Elsakova
Alexandra Elsakova
SLSini M. Laakso
Sini M. Laakso
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, and Epstein-Barr virus (EBV) infection is a prerequisite for developing the disease. However, the pathogenic mechanisms that lead to MS remain to be determined. Here, we characterized the immune landscape of deep cervical lymph nodes (dcLNs) in newly diagnosed untreated patients with MS (pwMS) using fine-needle aspirations. By combining single-cell RNA sequencing and cellular indexing of transcriptomes and epitopes by sequencing, we observed increased memory B cells and reduced germinal center B cells with decreased clonality in pwMS. Double-negative memory B cells were increased in pwMS that transcriptionally resembled B cells with a lytic EBV infection. Moreover, EBV-targeting memory CD8 T cells were detected in a subset of pwMS. We also detected increased EBV DNA in dcLNs and elevated viral loads in patient saliva. These findings suggest that EBV-driven B cell dysregulation is a critical mechanism in MS pathogenesis.

23 October 2023 in medRxiv
Verified
Preprint
Open access
PDF file
JSJoona Sarkkinen
Joona Sarkkinen
DYDawit Yohannes
Dawit Yohannes
NKNea Kreivi
Nea Kreivi
PDPia Dürnsteiner
Pia Dürnsteiner
JHJani Huuhtanen
Jani Huuhtanen
SLSini M Laakso
Sini M Laakso
Despite the recognized role of Epstein-Barr virus (EBV) in predisposing to multiple sclerosis (MS) and the effectiveness of B cell-depleting therapies in MS, the mechanism of autoimmunity remains elusive. Using fine needle aspirations, we investigated deep cervical lymph nodes (dcLNs), the primary site of the adaptive immune response against EBV, in newly diagnosed untreated MS patients and healthy controls. We characterized the immune landscape of dcLNs with scRNAseq and CITE- seq and observed increased memory B cell proportions and reduced germinal center (GC) B cells with decreased clonality in patients with MS compared to healthy controls. In the patient with an active MS relapse, we detected elevated plasmablasts, reduced GC B cells, and clonally expanded memory CD8 T cells targeting EBV in the dcLN. These findings, along with increased EBV DNA detection in dcLNs and viral loads in patient saliva, support B cell dysregulation as a key mechanism in MS pathogenesis.